Research
David Kranz’s lab been involved for many years in the discovery of immunotherapeutic approaches to cancer. The research program he leads is focused on the structure, function, and engineering of T cell receptors. The Kranz lab is interested in understanding the molecular basis of immune recognition by T cells, in tumor targeting with T cells and T cell-directed vaccines, and in engineering protein and cell-based therapeutics.
Education
- Ph.D., University of Illinois, 1982
Campus Affiliations
- Philip A Sharp Endowed Professor Emeritus, Biochemistry
Select Honors and Recognitions
- NAI Fellow, 2019
- JSMF Scholar Award in Researching Brain Cancer, 2005